Literature DB >> 11854899

Moving toward an understanding of the metastatic process in hepatocellular carcinoma.

W M Korn1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11854899      PMCID： PMC4695592          DOI： 10.3748/wjg.v7.i6.777

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  22 in total

1.  Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.

Authors:  K Endo; T Ueda; J Ueyama; T Ohta; T Terada
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.

Authors:  K Harada; G Shiota; H Kawasaki
Journal:  Liver       Date:  1999-08

4.  Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.

Authors:  T Ono; A Yamanoi; O Nazmy El Assal; H Kohno; N Nagasue
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

5.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

6.  Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma.

Authors:  H Miura; T Miyazaki; M Kuroda; T Oka; R Machinami; T Kodama; M Shibuya; M Makuuchi; Y Yazaki; S Ohnishi
Journal:  J Hepatol       Date:  1997-11       Impact factor: 25.083

7.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.

Authors:  P C Wu; J W Fang; V K Lau; C L Lai; C K Lo; J Y Lau
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.

Authors:  K Matsuzaki; M Date; F Furukawa; Y Tahashi; M Matsushita; K Sakitani; N Yamashiki; T Seki; H Saito; M Nishizawa; J Fujisawa; K Inoue
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

9.  Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.

Authors:  E Santoni-Rugiu; M R Jensen; S S Thorgeirsson
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

10.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701
View more
  14 in total

1.  Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

Authors:  Wen-Hua Xiao; Wei-Wen Liu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 2.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.

Authors:  Ying-Cheng Lin; Ming-Yao Wu; De-Rui Li; Xian-Ying Wu; Rui-Ming Zheng
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

4.  Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis.

Authors:  Peng Shang; Ai-Rong Qian; Tie-Hong Yang; Min Jia; Qi-Bing Mei; Chi-Hin Cho; Wen-Ming Zhao; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

5.  Expression and significance of RhoC gene in hepatocellular carcinoma.

Authors:  Wei Wang; Lian-Yue Yang; Zhi-Li Yang; Gen-Wen Huang; Wei-Qun Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.

Authors:  Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 7.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 8.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

9.  Biomarkers for hepatocellular carcinoma.

Authors:  Tara Behne; M Sitki Copur
Journal:  Int J Hepatol       Date:  2012-05-10

10.  Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.

Authors:  Lian-yue Yang; Wei-qun Lu; Geng-wen Huang; Wei Wang
Journal:  BMC Cancer       Date:  2006-05-02       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.